Skip to content

Combined Adductor&Sciatic Nerve Block vs Femoral&Sciatic Nerve Block in Total Knee Replacement Surgery

Comparing Combined Adductor Canal & Sciatic Nerve Block and Femoral & Sciatic Nerve Block for Postoperative Analgesia in Patients Undergoing Total Knee Replacement Surgery; A Prospective, Randomized, Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05648708
Enrollment
68
Registered
2022-12-13
Start date
2022-11-14
Completion date
2023-10-23
Last updated
2025-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopedic Disorder, Post Operative Pain, Surgery, Total Knee Replacement

Keywords

Femoral Nerve Block, Sciatic Nerve Block, Adductor Canal Block, General anesthesia, Orthopedic surgery, Post Operative Analgesia

Brief summary

Knee joints, one of the largest and most functional joints of the human body, have great features to provide ideal body posture and movement. In patients with knee osteoarthritis in whom pain and functional loss continue to increase despite conservative and medical burden, they are evaluated by orthopedic surgeons for surgical treatment. Total knee replacement (TKR) surgery is aimed to eliminate the existing pain, restore and carry the movements, to protect the characteristics of the deformities and the quality of life. Pain can be very severe after TKR surgery, which is very common in the middle and elderly patient population today. In the postoperative period, untreated pain prevents early physical therapy practices and restricts postoperative knee rehabilitation and recovery, but it also has negative effects on the respiratory, gastrointestinal, renal, and central nervous systems. Effective management of postoperative acute pain can reduce these complications and the risk of developing chronic pain. In this study, investigators hypothesized that combined adductor canal and sciatic nerve block, applied with postoperative ultrasound guidance to patients who will undergo TKR surgery under general anesthesia, will provide effective analgesia, less opioid consumption, and faster ambulation time, similar to combined femoral and sciatic nerve block.

Detailed description

As a result of the power analysis investigators conducted for this study, the minimum sample size was calculated as 34 people for each group, 68 people in total, at the 95% confidence interval. 68 patients who meet the inclusion criteria will be included in our study. Patients will be randomized and divided into 2 groups. Accordingly, femoral and sciatic nerve blocks will be applied to 34 patients, and adductor canal and sciatic nerve blocks will be applied to 34 patients.

Interventions

PROCEDURECombine Adductor Canal & Sciatic Nerve Block

The investigators will perform a combined adductor canal & sciatic nerve block on that patient group for postoperative analgesia

PROCEDURECombine Femoral & Sciatic Nerve Block

The investigators will perform a combined femoral & sciatic nerve block on that patient group for postoperative analgesia

DRUGBupivacaine and prilocaine hydrochloride

The investigators will perform a combined adductor canal & sciatic nerve block on that patient group for postoperative analgesia with bupivacaine and prilocaine hydrochloride

Sponsors

Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Ages of 40-85 * ASA I-III * Patients who will undergo total knee replacement surgery under general anesthesia

Exclusion criteria

* Patients with deformity and pathology in the thigh region * Clinically known local anesthetic allergy * Clinically diagnosis of opioid, alcohol and substance dependence * Patients who cannot perceive and evaluate pain such as psychiatric illness, mental retardation, dementia * Morbid obesity (body mass index\> 40 kg m2)

Design outcomes

Primary

MeasureTime frameDescription
The primary outcome measure of the study is the patients' postoperative pain scores (NRS)72 hours postoperativelyNumerical rating scale (NRS) at 1, 6, 12, 18, 24, 48, 72th hours. NRS assessment score ranges from 0-10. 0 = no pain 10 = worst pain imaginable

Secondary

MeasureTime frameDescription
The secondary outcome measure will be total opioid consumption in the first 72 hours postoperativelyThree days postoperativelyPCA device will be prepared with 4 mg tramadol (400 mg/100 cc) per ml and total opioid consumption for 72 hours will be noted

Other

MeasureTime frameDescription
Side effects due to postoperative opioid consumption, rescue analgesic requirements, hemodynamic parameters and satisfaction with analgesic methodThree days postoperativelyOpioid side effects ( Nausea, Vomiting, Constipation, Itching, Mental cloudiness, Sweating, Fatigue, Drowsiness ) will be evaluated and noted as none-mild-moderate-severe for 72 hours

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026